Detalhe da pesquisa
1.
Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus.
Liver Int
; 39(5): 967-975, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30735608
2.
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study.
Lancet
; 389(10074): 1114-1123, 2017 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28187915
3.
Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness.
Dig Dis Sci
; 63(10): 2547-2554, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29736833
4.
BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial.
BMC Gastroenterol
; 16(1): 71, 2016 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27431238
5.
Autoimmune hepatitis: an approach to disease understanding and management.
Br Med Bull
; 114(1): 181-91, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25995334
6.
Aspects of the Pathophysiology of Primary Biliary Cirrhosis.
Dig Dis
; 33 Suppl 2: 102-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26641487
7.
Hepatology training in the UK.
Lancet
; 387(10023): 1055, 2016 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27025183
8.
Palliative long-term abdominal drains for the management of refractory ascites due to cirrhosis: a consensus document.
Frontline Gastroenterol
; 13(e1): e116-e125, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35812034
9.
Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?
Can J Gastroenterol Hepatol
; 2022: 3618090, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523650
10.
Tunnelled peritoneal drainage catheter placement for the palliative management of refractory ascites in patients with liver cirrhosis.
Frontline Gastroenterol
; 12(2): 108-112, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33613941
11.
Barriers to implementation of stratified care in primary biliary cholangitis: a scoping exercise.
BMJ Open Gastroenterol
; 6(1): e000226, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31321066
12.
Intrahepatic macrophage populations in the pathophysiology of primary sclerosing cholangitis.
JHEP Rep
; 1(5): 369-376, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32039388
13.
Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol.
BMJ Open
; 7(6): e015081, 2017 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28674140
14.
Past violence, substance use, and precipitants to psychiatric patient assaults: eleven-year analysis of the Assaulted Staff Action Program (ASAP).
Int J Emerg Ment Health
; 8(3): 157-63, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16944788
15.
Autoimmune liver disease: evaluating overlapping and cross-over presentations-a case-based discussion.
Frontline Gastroenterol
; 7(4): 240-245, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28839864
16.
Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report.
JHEP Rep
; 1(1): 66-69, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32039353